Fig. 2From: Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trialTrial profile for the amyloid blood MAPT study. MAPT multidomain Alzheimer’s preventive trial, MI multidomain interventionBack to article page